{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:47:14Z","timestamp":1775116034290,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.abb.2022.109346","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:40:13Z","timestamp":1656981613000},"page":"109346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["NFIC1 suppresses migration and invasion of breast cancer cells through interferon-mediated Jak-STAT pathway"],"prefix":"10.1016","volume":"727","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanjuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueru","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youzhong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2022.109346_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.abb.2022.109346_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/1055-9965.EPI-18-0098","article-title":"Proportion of U.S. Trends in breast cancer incidence attributable to long-term changes in risk factor distributions","volume":"27","author":"Pfeiffer","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.abb.2022.109346_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ogc.2019.04.007","article-title":"Cancer screening in women","volume":"46","author":"Vogell","year":"2019","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.abb.2022.109346_bib4","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.abb.2022.109346_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2012.12.009","article-title":"DNA-binding specificities of human transcription factors","volume":"152","author":"Jolma","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.abb.2022.109346_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2017.09.015","article-title":"The convergent roles of the nuclear factor I transcription factors in development and cancer","volume":"410","author":"Chen","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.abb.2022.109346_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/mol.109.055699","article-title":"Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family","volume":"76","author":"Riffel","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.abb.2022.109346_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jb\/mvi128","article-title":"Transcriptional enhancement of UDP-glucuronosyltransferase form 1A2 (UGT1A2) by nuclear factor I-A (NFI-A) in rat hepatocytes","volume":"138","author":"Emi","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.abb.2022.109346_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41419-021-03661-4","article-title":"MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.abb.2022.109346_bib10","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/0008-5472.CAN-09-1677","article-title":"Nuclear Janus-activated kinase 2\/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1","volume":"70","author":"Nilsson","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2022.109346_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-015-1118-z","article-title":"Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.abb.2022.109346_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.abb.2022.109346_bib13","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1158\/0008-5472.CAN-05-3653","article-title":"Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma","volume":"66","author":"Lasfar","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2022.109346_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","article-title":"IFN-lambdas","volume":"23","author":"Kotenko","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.abb.2022.109346_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2009.10.002","article-title":"Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents","volume":"46","author":"Li","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.abb.2022.109346_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/1535-7163.MCT-09-0461","article-title":"Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis","volume":"9","author":"Guenterberg","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2022.109346_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/ol.2015.3890","article-title":"Recombinant adenovirus expressing hIFN-lambda1 inhibits gastric adenocarcinoma cell line SGC-7901 proliferation","volume":"11","author":"Bu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.abb.2022.109346_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/cgt.2016.29","article-title":"Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A\/IFN-lambda2 or IL-29\/IFN-lambda1","volume":"23","author":"Hasegawa","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.abb.2022.109346_bib19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ijc.28551","article-title":"CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-beta","volume":"134","author":"Jablonska","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.abb.2022.109346_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cyto.2015.11.012","article-title":"Interferon-beta gene transfer inhibits melanoma cells adhesion and migration","volume":"89","author":"Rossi","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.abb.2022.109346_bib21","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4161\/15384101.2014.949212","article-title":"PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2","volume":"13","author":"Kuo","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.abb.2022.109346_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4161\/auto.22831","article-title":"IFNB1\/interferon-beta-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function","volume":"9","author":"Ambjorn","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.abb.2022.109346_bib23","doi-asserted-by":"crossref","first-page":"13792","DOI":"10.1073\/pnas.1713728114","article-title":"Interferon-beta represses cancer stem cell properties in triple-negative breast cancer","volume":"114","author":"Doherty","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2022.109346_bib24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1073\/pnas.96.5.2082","article-title":"Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids","volume":"96","author":"Kochs","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2022.109346_bib25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-020-14727-w","article-title":"The anti-viral dynamin family member MxB participates in mitochondrial integrity","volume":"11","author":"Cao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2022.109346_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-016-3786-z","article-title":"MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer","volume":"156","author":"Kim","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.abb.2022.109346_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4143\/crt.2016.098","article-title":"Expression of myxovirus resistance A (MxA) is associated with tumor-infiltrating lymphocytes in human epidermal growth factor receptor 2 (HER2)-Positive breast cancers","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res. Treat"},{"key":"10.1016\/j.abb.2022.109346_bib28","doi-asserted-by":"crossref","first-page":"18762","DOI":"10.1002\/jcb.29189","article-title":"Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK\/P38\/NF-kappaB pathway in glioblastoma cells","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.abb.2022.109346_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav3942","article-title":"IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer","volume":"5","author":"Hubert","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.abb.2022.109346_bib30","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23353","article-title":"The tumor suppressor function of STAT1 in breast cancer","volume":"2","author":"Koromilas","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.abb.2022.109346_bib31","doi-asserted-by":"crossref","first-page":"E498","DOI":"10.1073\/pnas.1715118115","article-title":"Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma","volume":"115","author":"Lu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2022.109346_bib32","first-page":"89","article-title":"The regulation of beta-interferon gene expression","volume":"1","author":"Goodbourn","year":"1990","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.abb.2022.109346_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jcmgh.2021.08.019","article-title":"Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK\/STAT pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.abb.2022.109346_bib34","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat. Med."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122002302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122002302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:25:09Z","timestamp":1757744709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986122002302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"alternative-id":["S0003986122002302"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2022.109346","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NFIC1 suppresses migration and invasion of breast cancer cells through interferon-mediated Jak-STAT pathway","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2022.109346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109346"}}